Journal of the American Chemical Society p. 16766 - 16769 (2011)
Update date:2022-08-03
Topics:
Butora, Gabor
Kenski, Denise M.
Cooper, Abby J.
Fu, Wenlang
Qi, Ning
Li, Jenny J.
Flanagan, W. Michael
Davies, Ian W.
The RNA induced silencing complex (RISC) contains at its core the endonuclease Argonaute (Ago) that allows for guide strand (GS)-mediated sequence-specific cleavage of the target mRNA. Functionalization of the sugar/phosphodiester backbone of the GS, which is in direct contact with Ago, presents a logical opportunity to affect RISCs activity. A systematic evaluation of modified nucleosides requires the synthesis of phosphoramidites corresponding to all four canonical bases (A, U, C, and G) and their sequential evaluation at each position along the 21-nucleotide-long GS. With the use of a platform approach, the sequential replacement of canonical bases with inosine greatly simplifies the problem and defines a new activity baseline toward which the corresponding sugar-modified inosines are compared. This approach was validated using 2′-O-benzyl modification, which demonstrated that positions 5, 8, 15, and 19 can accommodate this large group. Application of this high-throughput methodology now allows for hypothesis-driven rational design of highly potent, immunologically silent and stable siRNAs suitable for therapeutic applications.
View MoreContact:86-516-66656369
Address:The west road of Huaihai, Xuzhou, China
website:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Doi:10.1016/S0040-4039(00)97087-4
(1990)Doi:10.1016/j.tetlet.2011.05.016
(2011)Doi:10.1021/jo2008093
(2011)Doi:10.1016/j.bmcl.2011.07.060
(2011)Doi:10.1002/chir.23052
(2019)Doi:10.1016/j.carres.2011.04.018
(2011)